Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
Clinical trial NCT01038739 · TERMINATED
Trial details
- NCT number
- NCT01038739
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2013-01-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.